Who: Kevin Fitzpatrick, 59
New role: Effective Aug. 3, he will become CEO of CancerLinQ, a not-for-profit subsidiary of the American Society of Clinical Oncology. CancerLinQ is a big data initiative launched in April. More than a dozen oncology groups already participate in the program, in which data are shared from millions of electronic health records, with the goal of providing real-time feedback on cancer trends and patient outcomes.
Current position: Executive VP and the first chief innovation officer at the American College of Cardiology. He leads financial management, operational and strategic planning initiatives.
Focus on quality improvement: Fitzpatrick was instrumental in the growth and development of Pinnacle, an office-based outpatient quality improvement registry focused on cardiovascular disease launched in 2008. By spring 2014, the registry included 23 performance measures and had submitted data for 1,236 providers across 96 practices to CMS' Physician Quality Reporting System and e-prescribing programs.
Oncology challenges: “Oncology is a rapidly evolving and data-intensive specialty that is on the forefront of precision medicine and genomics,” Fitzpatrick said. There is “urgent need” to develop a learning healthcare system that provides real-time decision support.